Publication

Development of fibrin derivatives for controlled release of heparin-binding growth factors

Related publications (46)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Development of fibrin derivatives for controlled release of heparin-binding growth factors

Graph Chatbot

Chat with Graph Search

Growth Factors Engineered for Super-Affinity to the Extracellular Matrix Enhance Tissue Healing

In-vivo single neuron axotomy triggers axon regeneration to restore synaptic density in specific cortical circuits

Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix

Tenascin C Promiscuously Binds Growth Factors via Its Fifth Fibronectin Type III-Like Domain

Development of a selective peptide macrocycle inhibitor of coagulation factor XII toward the generation of a safe antithrombotic therapy

An in vivo neovascularization assay for screening regulators of angiogenesis and assessing their effects on pre-existing vessels

Surface Microstructures on Planar Substrates and Textile Fibers Guide Neurite Outgrowth: A Scaffold Solution to Push Limits of Critical Nerve Defect Regeneration?

Engineering of Signaling Microenvironments with Fibronectin Domains to Enhance Tissue Regeneration

Biologicals and fetal cell therapy for wound healing and scar management

Rat bladder muscle regeneration induced by local delivery of an engineered insulin-like growth factor 1 in fibrin gels